Build · Google
Novartis — Strategic research collaboration (announced Jan 2024, expanded Feb 2025) to discover small-molecule therapeutics against challenging targets (up to 6 programs).
Google supplies AI to pharma through several distinct lines — Gemini/Vertex AI as an enterprise platform, and AlphaFold-based drug design licensed commercially through Isomorphic Labs.
This sits in the Build stage of the AI use-case lifecycle: Named examples from the foundation-model labs and platforms pharma teams use to actually construct, train and generate the model or application.
Source
Published by Google on its own site — read the original case study on isomorphiclabs.com ↗
More like this
Related use cases
- 01Built an AI-native operating system for drug discovery on Google Cloud, using deep learning to speed development and success rate of new treatments.
- 02AI/automation drug-development company; uses Google Cloud GPU/VM instances to accelerate drug discovery and lower computing costs.
- 03AI-based computational disease models on Google Cloud to help pharma shorten clinical trials and cut drug-development costs.
- 04Oncology biotech uses Google Cloud to scale molecular dynamics simulations, cutting simulation time from weeks to overnight and false positives by 50%.
- 05Built its protein-design platform (used across pharma/chemicals/food/ag R&D) on Google Cloud.
- 06AI-driven drug discovery company; moved to GKE for flexible, scalable protein-structure processing (millions of structures).